Stay updated on BGB324 with Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the BGB324 with Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the BGB324 with Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Melanoma is added as a related topic and MedlinePlus Genetics is listed under related topics. These changes serve as navigational aids and do not affect the study details.
    Difference
    0.2%
    Check dated 2026-01-06T23:23:18.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Removed Melanoma from related topics and the MedlinePlus Genetics link, reducing topic tagging; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-30T16:41:45.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    Footer updates include a new revision label 'Revision: v3.3.3' and removal of the previous label 'v3.3.2' and the 'HHS Vulnerability Disclosure' link. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T17:16:46.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    Added Melanoma and related topic MedlinePlus Genetics as related topics on the study page.
    Difference
    0.2%
    Check dated 2025-12-09T01:51:05.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    Melanoma and the related topic MedlinePlus Genetics were removed from the page's related topics; these changes affect metadata rather than the study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-01T22:42:58.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Summary
    Minor site revision update from v3.2.0 to v3.3.2; no changes to the study details, endpoints, or eligibility criteria were observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T21:03:29.000Z thumbnail image

Stay in the know with updates to BGB324 with Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the BGB324 with Pembrolizumab in Melanoma Clinical Trial page.